Litigation Details for Purdue Pharmaceutical v. Actavis Elizabeth LLC (Fed. Cir. 2015)
✉ Email this page to a colleague
Purdue Pharmaceutical v. Actavis Elizabeth LLC (Fed. Cir. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-05-13 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | 6,024,981; 6,200,604; 6,264,981; 6,264,987; 6,383,471; 6,514,531; 6,589,556; 6,720,001; 6,759,059; 6,761,910; 7,658,945; 7,682,628; 8,242,131; 8,252,809 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Purdue Pharmaceutical v. Actavis Elizabeth LLC
Biologic Drugs cited in Purdue Pharmaceutical v. Actavis Elizabeth LLC
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for Purdue Pharmaceutical v. Actavis Elizabeth LLC (Fed. Cir. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2015-07-13 | 43 | 5,965,162 A 10/1999 Fuisz et al. 6,024,981 A 2/2000 Khankari et al. …are U.S. Patent No. 8,242,131 (the “’131 patent”), U.S. Patent No. 7,682,628 (the “’628 patent”), and … multiple patents for its advances; including U.S. Patent Nos. 8,242,131 (the “’131 Patent”); 8,252,809… The ’809 patent is a patent indicated for the treatment of MOTN insomnia. The ’131 patent is directed…’628 Patent, February 17, 2004; 2) for the ’131 Patent, May 25, 2005; and 3) for the ’809 Patent, May | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
